Literature DB >> 12123863

Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats.

Kimio Sugaya1, Saori Nishijima, Minoru Miyazato, Katsuhiro Ashitomi, Tadashi Hatano, Yoshihide Ogawa.   

Abstract

The effects of intrathecal injection of tamsulosin (an alpha-1A adrenergic receptor antagonist) and naftopidil (an alpha-1D adrenergic receptor antagonist) on isovolumetric bladder contraction were investigated in rats under urethane anesthesia. Intrathecal injection of tamsulosin (10-30 microg) or naftopidil (0.1-30 microg) transiently abolished isovolumetric rhythmic bladder contraction. Following the recovery of bladder contraction, the interval between contractions was the same as the control value before the injection. The amplitude of bladder contraction was decreased by intrathecal injection of naftopidil (3-30 microg), but not by tamsulosin. Therefore, in addition to the antagonistic action of these agents on the alpha-1 adrenergic receptors of prostatic smooth muscle, both agents (especially naftopidil) may also act on the lumbosacral cord, and thus may improve collecting disorders in patients with benign prostatic hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12123863     DOI: 10.1016/s0304-3940(02)00459-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

Review 1.  Neural control of the lower urinary tract.

Authors:  William C de Groat; Derek Griffiths; Naoki Yoshimura
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

2.  Effects of an alpha-1d adrenoreceptor antagonist (naftopidil) on bladder dysfunction after radiotherapy in female rats.

Authors:  Sung Jong Lee; Hee Youn Kim; Dong Sup Lee
Journal:  Int Urogynecol J       Date:  2020-08-06       Impact factor: 2.894

3.  Selective α1A-blocker improves bladder storage function in rats via suppression of C-fiber afferent activity.

Authors:  Osamu Yokoyama; Hideaki Ito; Yoshitaka Aoki; Nobuyuki Oyama; Yoshiji Miwa; Hironobu Akino
Journal:  World J Urol       Date:  2009-10-16       Impact factor: 4.226

Review 4.  Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.

Authors:  Martin C Michel; Wim Vrydag
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 5.  Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction : implications for sexual dysfunction.

Authors:  Serap Gur; Philip J Kadowitz; Wayne J G Hellstrom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Effects of Spinal and Peripheral Injection of α1A or α1D Adrenoceptor Antagonists on Bladder Activity in Rat Models with or without Bladder Outlet Obstruction.

Authors:  Jae Heon Kim; Ji Sung Shim; Seung Chul Kang; Kang Soo Shim; Jae Young Park; Du Geon Moon; Jeong Gu Lee; Jae Hyun Bae
Journal:  Int Neurourol J       Date:  2011-12-31       Impact factor: 2.835

7.  A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement.

Authors:  Chenthil Perumal; Puskar Shyam Chowdhury; N Ananthakrishnan; Prasant Nayak; Srinivasan Gurumurthy
Journal:  Urol Ann       Date:  2015 Jan-Mar

8.  Clinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open-Label Study.

Authors:  Mun Su Chung; Byung Il Yoon; Seung Hwan Lee
Journal:  Yonsei Med J       Date:  2017-07       Impact factor: 2.759

9.  Catecholaminergic Gene Polymorphisms Are Associated with GI Symptoms and Morphological Brain Changes in Irritable Bowel Syndrome.

Authors:  Alexa Orand; Arpana Gupta; Wendy Shih; Angela P Presson; Christian Hammer; Beate Niesler; Nuwanthi Heendeniya; Emeran A Mayer; Lin Chang
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

Review 10.  Management of benign prostatic hyperplasia with silodosin.

Authors:  Tomonori Yamanishi; Tomoya Mizuno; Takao Kamai; Ken-Ichiro Yoshida; Ryuji Sakakibara; Tomoyuki Uchiyama
Journal:  Open Access J Urol       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.